Alex Adjei Selected Research

human FLT4 protein

3/2013

Lung cancer lymph node micrometastasis detection using real-time polymerase chain reaction: correlation with vascular endothelial growth factor expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alex Adjei Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 05/2003
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2018 - 12/2005
4	Malaria 01/2020 - 04/2015
3	Nausea 01/2018 - 02/2005
2	Exanthema (Rash) 01/2018 - 10/2016
2	Diarrhea 01/2018 - 10/2016
2	Fatigue 01/2018 - 10/2016
2	Vomiting 10/2016 - 02/2005
2	Carcinoma (Carcinomatosis) 03/2013 - 06/2007
2	Lung Neoplasms (Lung Cancer) 03/2013 - 11/2008
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2020
1	Body Weight (Weight, Body) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Edema (Dropsy) 10/2016
1	Melanoma (Melanoma, Malignant) 10/2016
1	Neoplasm Micrometastasis 03/2013
1	Basal Cell Carcinoma (Rodent Ulcer) 09/2011
1	Medulloblastoma 09/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2007
1	Circulating Neoplastic Cells 06/2007
1	Prostatic Neoplasms (Prostate Cancer) 06/2007
1	Hot Flashes 01/2006
1	Anemia 02/2005

Drug/Important Bio-Agent (IBA)

3	artenimol (dihydroartemisinin)IBA 01/2020 - 01/2016
3	piperaquineIBA 01/2020 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 03/2013 - 05/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 03/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 02/2012
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 11/2018 - 06/2007
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2017
1	cediranib (AZD2171)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	AZD 6244IBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 12/2021
1	Gemcitabine FDA Link 12/2021
1	ceritinibIBA 12/2021
1	Proto-Oncogene Proteins c-metIBA 12/2021
1	Anaplastic Lymphoma KinaseIBA 12/2021
1	tipifarnib (R115777)IBA 01/2019
1	Farnesyltranstransferase (Farnesyltransferase)IBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	AntibodiesIBA 11/2018
1	XL647IBA 01/2018
1	cobimetinibIBA 10/2016
1	erioniteIBA 01/2016
1	Mineral Fibers (Mineral Fiber)IBA 01/2016
1	AsbestosIBA 01/2016
1	artemisinin (artemisinine)IBA 04/2015
1	Pemetrexed (MTA)FDA Link 11/2013
1	human FLT4 proteinIBA 03/2013
1	Vascular Endothelial Growth FactorsIBA 03/2013
1	Vascular Endothelial Growth Factor DIBA 03/2013
1	Vascular Endothelial Growth Factor CIBA 03/2013
1	Carcinoembryonic AntigenIBA 03/2013
1	Messenger RNA (mRNA)IBA 03/2013
1	Keratin-7 (Cytokeratin 7)IBA 03/2013
1	Cell Adhesion MoleculesIBA 03/2013
1	cixutumumabIBA 02/2012
1	Insulin (Novolin)FDA Link 02/2012
1	Monoclonal AntibodiesIBA 02/2012
1	Immunoglobulin G (IgG)IBA 02/2012
1	Orosomucoid (Seromucoid)IBA 09/2011
1	HhAntag691IBA 09/2011
1	Bevacizumab (Avastin)FDA Link 01/2008
1	Etoposide (VP 16)FDA LinkGeneric 07/2007
1	Cisplatin (Platino)FDA LinkGeneric 07/2007
1	Hormones (Hormone)IBA 06/2007
1	Insulin-Like PeptidesIBA 06/2007
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 06/2007
1	figitumumabIBA 06/2007
1	Dehydroepiandrosterone (DHEA)IBA 01/2006
1	tanespimycin (17AAG)IBA 02/2005
1	BilirubinIBA 02/2005
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 05/2003
1	sibrotuzumabIBA 05/2003

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 12/2021 - 12/2005
4	Therapeutics 11/2008 - 12/2005
1	Cranial Irradiation 07/2007
1	Radiotherapy 07/2007
1	Gamma Cameras (Gamma Camera) 05/2003